Search

everythinglearnresearchcommunity

for

Search:↓

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

The article helps identify common, non-harmful skin conditions in newborns to avoid undue concern and treatment.

Testosterone is crucial for development, growth, and various body functions in mammals.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Placental mesenchymal stem cells and their conditioned medium significantly improve healing in local radiation injuries.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Improve chin and perioral scars with surgery, resurfacing, and other therapies, tailored to each patient.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Combining physical dermabrasion with chemical peeling is more effective for skin treatment than chemical peeling alone.

Some horses lose hair without inflammation or itching due to various conditions, and while mainly a cosmetic issue, diagnosis requires examination and biopsies, and breeding is not advised if it's hereditary.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Choline and biotin are important for liver health and preventing certain deficiencies in animals, and more research is needed to understand their benefits in humans.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

The conclusion is that pharmacists are important in helping women choose the right skin care treatments.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.